Total Payments
$3,539
2024 Payments
$501.80
Companies
17
Transactions
237
Medicare Patients
11,787
Medicare Billing
$759,885
Payment Breakdown by Category
Food & Beverage$3,241 (91.6%)
Education$297.99 (8.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,241 | 234 | 91.6% |
| Education | $297.99 | 3 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,107 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $714.20 | 38 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $337.71 | 24 | $0 (2024) |
| Lilly USA, LLC | $251.13 | 13 | $0 (2022) |
| PruGen, Inc. Pharmaceuticals | $214.92 | 4 | $0 (2020) |
| GENZYME CORPORATION | $184.06 | 9 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $159.86 | 10 | $0 (2024) |
| PFIZER INC. | $136.61 | 10 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $119.97 | 5 | $0 (2023) |
| UCB, Inc. | $99.98 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $501.80 | 38 | ABBVIE INC. ($253.01) |
| 2023 | $333.26 | 23 | AbbVie Inc. ($148.86) |
| 2022 | $364.46 | 31 | ABBVIE INC. ($191.28) |
| 2021 | $528.87 | 39 | AbbVie Inc. ($181.45) |
| 2020 | $324.95 | 17 | AbbVie Inc. ($159.81) |
| 2019 | $800.90 | 47 | Janssen Biotech, Inc. ($174.92) |
| 2018 | $465.14 | 24 | Janssen Biotech, Inc. ($170.12) |
| 2017 | $219.24 | 18 | Janssen Biotech, Inc. ($129.68) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 2 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Immunology | ||||||
| 02/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Dermatology | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Dermatology | ||||||
| 01/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.71 | General |
| Category: Immunology | ||||||
| 01/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Immunology | ||||||
| 10/19/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Immunology | ||||||
| 09/26/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CNS | ||||||
| 08/16/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.74 | General |
| 08/01/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,179 | 5,682 | $603,694 | $206,253 |
| 2022 | 22 | 3,063 | 5,453 | $564,276 | $197,714 |
| 2021 | 21 | 2,903 | 4,975 | $533,478 | $198,089 |
| 2020 | 18 | 2,642 | 4,614 | $457,876 | $157,829 |
Total Patients
11,787
Total Services
20,724
Medicare Billing
$759,885
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 619 | 733 | $115,814 | $39,904 | 34.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 376 | 424 | $74,301 | $28,392 | 38.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 584 | 708 | $85,248 | $27,347 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 288 | $64,224 | $24,261 | 37.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 468 | 2,539 | $66,014 | $12,084 | 18.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 68 | 89 | $23,680 | $10,172 | 43.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 145 | 145 | $28,420 | $8,876 | 31.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 60 | 72 | $25,272 | $8,333 | 33.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 96 | 101 | $19,996 | $8,170 | 40.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 33 | 33 | $17,664 | $6,907 | 39.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 114 | 172 | $16,684 | $6,507 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $15,741 | $5,767 | 36.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 142 | 154 | $15,246 | $5,499 | 36.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 36 | 36 | $8,208 | $3,170 | 38.6% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 23 | 26 | $7,650 | $3,137 | 41.0% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 15 | 16 | $5,220 | $2,076 | 39.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 39 | 39 | $5,343 | $1,833 | 34.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $2,486 | $1,087 | 43.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 16 | $2,464 | $1,070 | 43.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $2,244 | $892.72 | 39.8% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 14 | 16 | $1,776 | $767.18 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 631 | 769 | $111,858 | $42,462 | 38.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 356 | 402 | $68,509 | $28,217 | 41.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 536 | 654 | $79,846 | $25,531 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 172 | $35,652 | $12,773 | 35.8% |
About Dr. Andrew Tegeder, MD
Dr. Andrew Tegeder, MD is a Dermatology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1376835769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Tegeder, MD has received a total of $3,539 in payments from pharmaceutical and medical device companies, with $501.80 received in 2024. These payments were reported across 237 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,241).
As a Medicare-enrolled provider, Tegeder has provided services to 11,787 Medicare beneficiaries, totaling 20,724 services with total Medicare billing of $759,885. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Missoula, MT
- Active Since 05/04/2011
- Last Updated 06/28/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376835769
Products in Payments
- SKYRIZI (Biological) $613.94
- Tremfya (Drug) $396.82
- TALTZ (Drug) $251.13
- RINVOQ (Biological) $197.02
- Sotyktu (Drug) $159.86
- TREMFYA (Drug) $155.95
- COSENTYX (Biological) $155.22
- DUPIXENT (Biological) $140.00
- COSENTYX (Drug) $139.96
- Humira (Biological) $135.22
- HUMIRA (Biological) $123.45
- EUCRISA (Drug) $122.41
- DUPIXENT DUPILUMAB INJECTION (Biological) $100.26
- Cimzia (Drug) $99.98
- REMICADE (Biological) $83.53
- STELARA (Biological) $77.90
- ILUMYA (Biological) $48.29
- DUPIXENT (Drug) $41.33
- Skyrizi (Biological) $36.95
- Puraply (Medical Supply) $32.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Missoula
Shannon Foster, M.d, M.D
Dermatology — Payments: $11,217
Dermatology $11,217
Troy Davis, Pa-C, PA-C
Dermatology — Payments: $5,646
Dermatology $5,646
Jessica Sempler, M.d, M.D
Dermatology — Payments: $5,358
Dermatology $5,358
Erika Hagstrom, Md, MD
Dermatology — Payments: $1,643
Dermatology $1,643
Jacob Inda, Md, MD
Dermatology — Payments: $1,488
Dermatology $1,488
Allyson Yelich, D.o, D.O
Dermatology — Payments: $843.25
Dermatology $843.25